Lutgens et al identified risk factors for colorectal cancer in a patient with inflammatory bowel disease. This can help to identify a patient who may benefit from closer surveillance. The authors are from University Medical Center Utrecht, University of California Los Angeles and University Hospital Gasthuisberg in Leuven.
